Weiss Ratings Reaffirms Hold (C+) Rating for Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health (NYSE:HIMS)‘s stock had its “hold (c+)” rating restated by equities researchers at Weiss Ratings in a research report issued on Tuesday,Weiss Ratings reports.

Several other equities research analysts have also recently issued reports on the company. Canaccord Genuity Group reiterated a “buy” rating and issued a $68.00 price target on shares of Hims & Hers Health in a research note on Friday, September 12th. Truist Financial cut their price target on Hims & Hers Health from $48.00 to $37.00 and set a “hold” rating for the company in a research note on Monday, August 18th. Wall Street Zen cut Hims & Hers Health from a “buy” rating to a “hold” rating in a research note on Monday, July 28th. Zacks Research cut Hims & Hers Health from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 19th. Finally, UBS Group set a $30.00 target price on Hims & Hers Health in a research note on Monday, June 23rd. Two research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, Hims & Hers Health presently has a consensus rating of “Reduce” and a consensus price target of $38.92.

Hims & Hers Health Trading Up 16.2%

Shares of NYSE:HIMS opened at $62.79 on Tuesday. Hims & Hers Health has a 12-month low of $18.33 and a 12-month high of $72.98. The stock has a market cap of $14.19 billion, a PE ratio of 78.49, a P/E/G ratio of 3.69 and a beta of 2.25. The business has a 50 day moving average of $50.89 and a 200-day moving average of $48.43. The company has a quick ratio of 4.46, a current ratio of 4.98 and a debt-to-equity ratio of 1.72.

Hims & Hers Health (NYSE:HIMS) last issued its quarterly earnings data on Monday, August 4th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The firm had revenue of $544.83 million for the quarter, compared to the consensus estimate of $550.06 million. Hims & Hers Health had a return on equity of 26.26% and a net margin of 9.63%.The company’s revenue was up 72.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.06 EPS. Hims & Hers Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities research analysts forecast that Hims & Hers Health will post 0.29 earnings per share for the current year.

Insider Transactions at Hims & Hers Health

In other news, insider Patrick Harrison Carroll sold 60,000 shares of the company’s stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $53.58, for a total transaction of $3,214,800.00. Following the completion of the transaction, the insider directly owned 169,940 shares in the company, valued at approximately $9,105,385.20. This represents a 26.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Oluyemi Okupe sold 145,000 shares of the company’s stock in a transaction on Monday, September 15th. The stock was sold at an average price of $55.35, for a total transaction of $8,025,750.00. Following the transaction, the chief financial officer owned 128,984 shares of the company’s stock, valued at $7,139,264.40. This trade represents a 52.92% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,561,799 shares of company stock worth $80,686,085. Corporate insiders own 13.71% of the company’s stock.

Institutional Trading of Hims & Hers Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Virtus Advisers LLC acquired a new stake in Hims & Hers Health in the second quarter valued at $26,000. Quaker Wealth Management LLC acquired a new stake in Hims & Hers Health in the second quarter valued at $29,000. Bessemer Group Inc. increased its holdings in Hims & Hers Health by 105.8% in the second quarter. Bessemer Group Inc. now owns 607 shares of the company’s stock valued at $30,000 after purchasing an additional 312 shares during the period. Hilltop National Bank acquired a new stake in Hims & Hers Health in the third quarter valued at $35,000. Finally, Skandinaviska Enskilda Banken AB publ increased its holdings in Hims & Hers Health by 408.2% in the second quarter. Skandinaviska Enskilda Banken AB publ now owns 747 shares of the company’s stock valued at $37,000 after purchasing an additional 600 shares during the period. 63.52% of the stock is currently owned by institutional investors and hedge funds.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.